Uterine Sarcoma or Degenerating Fibroid? Validating the New Consensus Magnetic Resonance Imaging Algorithm for...

Area of Science:

• Radiology
• Oncology
• Gynecologic Pathology

Background:

• Differentiating uterine leiomyomas from uterine malignancies can be challenging.
• A consensus diagnostic algorithm using magnetic resonance imaging (MRI) was recently proposed.
• Accurate differentiation is crucial for appropriate patient management.

Purpose of the Study:

• To assess the diagnostic validity of a new consensus MRI algorithm.
• To evaluate its performance in distinguishing degenerating leiomyomas from uterine sarcomas and other malignant uterine masses.
• To determine the algorithm's sensitivity, specificity, and predictive values.

Main Methods:

• Retrospective review of 40 pathology-proven atypical uterine masses on pelvic MRI.
• Two blinded radiologists independently applied the 2022 consensus atypical uterine mass flowchart.
• Assessed imaging features included T2 signal intensity, diffusion-weighted imaging signal, apparent diffusion coefficient (ADC) values, and nodal status.

Main Results:

• The algorithm demonstrated high accuracy: Reader 1 (75% sensitivity, 95.8% specificity) and Reader 2 (81.2% sensitivity, 91.7% specificity).
• Positive predictive value was 92.3% (Reader 1) and 86.7% (Reader 2); negative predictive value was 85% (Reader 1) and 88% (Reader 2).
• Interrater agreement was strong (kappa = 0.89); sensitivity and NPV improved to 100% when excluding non-leiomyosarcoma malignancies.

Conclusions:

• The consensus MRI algorithm is effective for diagnosing uterine malignancy, particularly uterine leiomyosarcomas.
• Caution is advised if ADC values are near the threshold, especially with lower b-values.
• Morphological features on T2 and post-contrast sequences are important for atypical endometrial masses with higher ADC values.